American Journal of Epidemiology Advance Access originally published online on August 14, 2007
American Journal of Epidemiology 2007 166(10):1150-1158; doi:10.1093/aje/kwm195
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ORIGINAL CONTRIBUTIONS |
Nonsteroidal Antiinflammatory Drugs and Breast Cancer Risk
The Multiethnic Cohort
1 Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HI
2 Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA
Correspondence to Dr. Jasmeet K. Gill, Cancer Research Center of Hawaii, 1236 Lauhala Street, Honolulu, HI 96813 (e-mail: jgill{at}crch.hawaii.edu).
Received for publication March 19, 2007. Accepted for publication May 31, 2007.
Previous studies on nonsteroidal antiinflammatory drugs (NSAIDs) and breast cancer have produced mixed results. Incident invasive cases of breast cancer from the Multiethnic Cohort (African Americans, Caucasians, Japanese Americans, Latinas, and Native Hawaiians from Hawaii and California) were identified from 1993 to 2002. Data on aspirin, acetaminophen, and other NSAID (ibuprofen, naproxen, indomethacin) use were based on a self-administered questionnaire at baseline (1993–1996). Multivariate Cox proportional hazards models provided estimates of hazard rate ratios and 95% confidence intervals. The authors observed no associations between breast cancer risk and duration of aspirin use for current or past users (hazard rate ratio = 1.05, 95% confidence interval: 0.88, 1.25 and hazard rate ratio = 1.04, 95% confidence interval: 0.84, 1.27 for 
6 years of use, respectively) compared with nonusers. However, duration of current other NSAID use was protective (hazard rate ratio = 0.70, 95% confidence interval: 0.51, 0.95 for 6 years of use; ptrend = 0.01) against the risk of breast cancer, while past use was not (hazard rate ratio = 0.90, 95% confidence interval: 0.62, 1.30 for 6 years of use). Analyses by ethnicity and hormone receptor status showed that the protective effect of current other NSAID use was limited to Caucasians and African Americans and to women with at least one positive hormone receptor. This study found duration of current other NSAID use to be protective against breast cancer risk.
anti-inflammatory agents, non-steroidal; breast neoplasms; ethnic groups; risk
Abbreviations: CI, confidence interval; COX, cyclooxygenase; NSAID, nonsteroidal antiinflammatory drug
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Takkouche, C. Regueira-Mendez, and M. Etminan Breast Cancer and Use of Nonsteroidal Anti-inflammatory Drugs: A Meta-analysis J Natl Cancer Inst, October 15, 2008; 100(20): 1439 - 1447. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. R. Howe and S. M. Lippman Modulation of Breast Cancer Risk by Nonsteroidal Anti-inflammatory Drugs J Natl Cancer Inst, October 15, 2008; 100(20): 1420 - 1423. [Full Text] [PDF]
|
|